LISTED medication adherence firm MedAdvisor is gearing up for international growth, with an ASX update yesterday confirming it had aligned its information security compliance systems to address US Health Insurance Probity and Accountability Act regulations.
CEO Robert Read said MedAdvisor was investing $3m "to make our product and business ready for US expansion".
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Feb 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Feb 19
